WallStreetZenWallStreetZen

NYSE: EBS
Emergent Biosolutions Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Emergent Biosolutions earnings were -$190.6M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest EBS earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$31.3M, down 127.3% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, EBS reported annual earnings of -$190.6M, with -74.9% growth.

EBS earnings history

Current Revenue
$1.0B
Current Earnings
-$190.6M
Current Profit Margin
-18.3%

EBS Return on Equity

Current Company
-37.3%
Current Industry
12.5%
Current Market
34.1%
EBS's Return on Equity (-37.3%)... subscribe to Premium to read more.
High Return on Equity Performance

EBS undefined

Current Company
-12.3%
Current Industry
5.5%
EBS is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when EBS announces earnings.

EBS undefined

Current Company
-5.86%
Current Industry
12%
EBS's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

EBS vs Pharmaceutical Stocks

TickerEBITDAEarningsY/Y EarningsEPS
EBS$36.90M-$190.60MN/A-$3.60
AQST-$26.62M-$44.14MN/A-$0.51
ACB$18.57M-$15.26MN/A-$3.00
LFCR-$14.23M-$49.40MN/A-$1.48
TKNO-$19.39M-$26.75MN/A-$0.57
View Top Pharmaceutical Stocks

Emergent Biosolutions Earnings Reports & History FAQ

What were Emergent Biosolutions's earnings last quarter?

On EBS's earnings call on Invalid Date, Emergent Biosolutions (NYSE: EBS) reported Q4 2024 earnings per share (EPS) of -$0.57, up 35.23% year over year. Total EBS earnings for the quarter were -$31.30 million. In the same quarter last year, Emergent Biosolutions's earnings per share (EPS) was -$0.88.

If you're new to stock investing, here's how to buy Emergent Biosolutions stock.

Is Emergent Biosolutions profitable or losing money?

As of the last Emergent Biosolutions earnings report, Emergent Biosolutions is currently losing money. Emergent Biosolutions's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$190.60 million, a 74.94% decrease year over year.

What was EBS's earnings growth in the past year?

As of Emergent Biosolutions's earnings date in Invalid Date, Emergent Biosolutions's earnings has grown year over year. EBS earnings in the past year totalled -$190.60 million.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.